Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5609
Abstract: The optimal treatment for vitreoretinal lymphoma (VRL) remains a challenge, as central nervous system (CNS) relapse occurs frequently, leading to the worst impact on survival. We previously proposed combined intravitreal methotrexate and systemic high‐dose methotrexate… read more here.
Keywords: combined intravitreal; vitreoretinal lymphoma; systemic high; methotrexate ... See more keywords
Paraneoplastic acute exudative polymorphous vitelliform maculopathy improved with intravitreal methotrexate
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2020.100930
Abstract: Purpose To describe a case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated with intravitreal methotrexate. Observations A 58-year-old man with a history of metastatic melanoma developed paraneoplastic acute exudative polymorphous vitelliform maculopathy, refractory to… read more here.
Keywords: exudative polymorphous; vitelliform maculopathy; polymorphous vitelliform; intravitreal methotrexate ... See more keywords
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Retina and Vitreous"
DOI: 10.1186/s40942-021-00346-0
Abstract: Purpose To describe the visual acuity and anatomic outcomes of intravitreal methotrexate (MTX) for the treatment of primary vitreoretinal lymphoma (PVRL). Methods Single-center retrospective case series of patients with a diagnosis of PVRL treated with… read more here.
Keywords: time; intravitreal methotrexate; lymphoma; treatment ... See more keywords